Aimei Health Technology AFJK
NASDAQ AFJK
$12.56 +0.23 (+1.87%)
As of: Aug 21, 2026 · 3:59 PM EDT

Aimei Health Technology (AFJK) Net Cash Flow (2024 - 2025)

Aimei Health Technology (AFJK) posted quarterly Net Cash Flow of $841.0 for Q3 2025, up 101.56% year-over-year from $417.25 in Q3 2024, and up 116.15% quarter-over-quarter from -$5207.0 in Q2 2025.

Aimei Health Technology (AFJK) Net Cash Flow (2024 - 2025) Analysis & Trends

Aimei Health Technology (AFJK) has reported Net Cash Flow for 2 consecutive years, with $841.0 the latest figure, recorded in Q3 2025.

  • In Q3 2025, Net Cash Flow rose 101.56% year-over-year to $841.0; the TTM figure through Dec 2025 stood at -$25229.0 (up 96.25% YoY), while the FY2024 annual figure was -$552509.0, down 195.14% from the prior year.
  • Net Cash Flow improved to $841.0 in Q3 2025 per AFJK's latest filing, from -$5207.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $841.0 in Q3 2025 and bottomed at -$256242.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - -162,173.00
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - -109,362.00
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - -
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - -
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - -
6 Aldel Financial 397.49 Mn 397.49 Mn - -81,520.00
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - -58,765.00
8 Gores Holdings X 385.06 Mn 384.87 Mn - -236,785.00
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - -
10 Aimei Health Technology 50.90 Mn 50.89 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 841.00
Sep 30, 2025 841.00
Jun 30, 2025 -5,207.00
Jun 30, 2025 -5,207.00
Mar 31, 2025 -20,863.00
Mar 31, 2025 -20,863.00
Dec 31, 2024 -195,131.00
Dec 31, 2024 -195,131.00
Sep 30, 2024 -53,946.00
Sep 30, 2024 -53,946.00
Jun 30, 2024 -256,242.00
Jun 30, 2024 -256,242.00
Mar 31, 2024 -166,970.00
Mar 31, 2024 -166,970.00